RE: expectations for Q earnings are lowThis is all but understood when investing in the biotech sector, as there are many companies out there in this sector which Q earnings in the negative as they do not have any revenues as of yet. They are drug development companies and thus have a burn rate that exceedes any revenues they may have. This should not come as a surprise to anyone.
CC